Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Apr 30, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of rehabilitation after ACL (anterior cruciate ligament) surgery can affect the risk of developing osteoarthritis in the knee. Researchers want to find out if adding whole body vibration (WBV) or local muscle vibration (LMV) to standard rehabilitation can improve muscle function, walking patterns, and overall knee health. Participants will be divided into three groups: one receiving standard rehab, another with standard rehab plus WBV, and the last with standard rehab plus LMV. They will undergo various assessments at 1, 6, and 12 months after their surgery to see how these different approaches impact their recovery.
To be eligible for this trial, participants should be between 16 and 35 years old and have undergone a primary ACL reconstruction surgery using a specific type of graft. Those who have had previous knee injuries or surgeries, or certain other medical conditions, will not be eligible. Throughout the trial, participants can expect regular check-ins to evaluate their muscle strength, movement patterns, and knee health through tests and MRI scans, helping researchers understand if vibration therapy can enhance rehabilitation outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 16 to 35 years
- • Unilateral, primary ACLR with bone-patellar tendon-bone autograft
- Exclusion Criteria:
- • History of prior ACL injury or revision ACLR
- • History of prior knee surgery
- • Requirement of multiple ligament surgery at time of ACLR
- • Concomitant injuries or surgical procedures at the time of ACLR that would delay early post-operative weight bearing based on surgeon recommendations (e.g. lower extremity fracture, intra-articular fracture, microfracture procedure)
- • Removal of more than 1/3 of the medial or lateral meniscus at the time of ACLR
- • Articular cartilage damage greater than 3A on the International Cartilage Repair Society Criteria at the time of ACLR
- • History of musculoskeletal injury to either leg in the 3 months prior to participation other than primary ACL injury
- • Prior diagnosis of radiographic OA in any joint of the lower extremity
- • History of neurological disorder (e.g. stroke, multiple sclerosis, etc.)
- • Contraindications for MRI (e.g. extreme claustrophobia, cardiac pacemaker, cochlear implant, metal foreign bodies, aneurism clip, etc.)
- • Pregnant or planning to become pregnant
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Troy Blackburn, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials